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Abstract
Background: The H10 subtype avian influenza viruses (H10N4, H10N5 and H10N7) have been reported to cause
disease in mammals, and the first human case of H10N8 subtype avian influenza virus was reported in 2013. Recently,
H10 subtype avian influenza viruses (AIVs) have been followed more closely, but routine diagnostic tests are tedious,
less sensitive and time consuming, rapid molecular detection assays for H10 AIVs are not available.
Methods: Based on conserved sequences within the HA gene of the H10 subtype AIVs, specific primer sets of H10
subtype of AIVs were designed and assay reaction conditions were optimized. A reverse-transcription loop-mediated
isothermal amplification (RT-LAMP) assay was established for the rapid detection of H10 subtype AIVs. The specificity
was validated using multiple subtypes of AIVs and other avian respiratory pathogens, and the limit of detection (LOD)
was tested using concentration gradient of in vitro-transcribed RNA.
Results: The established assay was performed in a water bath at 63 °C for 40 min, and the amplification result was
visualized directly as well as under daylight reflections. The H10-RT-LAMP assay can specifically amplify H10 subtype AIVs
and has no cross-reactivity with other subtypes AIVs or avian pathogens. The LOD of the H10-RT-LAMP assay was 10
copies per μL of in vitro-transcribed RNA.
Conclusions: The RT-LAMP method reported here is demonstrated to be a potentially valuable means for the detection
of H10 subtype AIV and rapid clinical diagnosis, being fast, simple, and low in cost. Consequently, it will be a very useful
screening assay for the surveillance of H10 subtype AIVs in underequipped laboratories as well as in field conditions.
Introduction
The influenza A viruses belong to the family Orthomyxo-
viridae and are classified into 18 hemagglutinin (HA) and
11 neuraminidase (NA) subtypes based on their antigenic
properties [1, 2]. Avian influenza viruses (AIVs) can be
divided into two distinct groups based on their virulence:
highly pathogenic avian influenza viruses (HPAIVs) and low
pathogenic avian influenza viruses (LPAIVs). HPAIVs
generally cause high morbidity and mortality in poultry
flock, even directly infect human or cause death such as
H5N1 in Hong Kong in 1997 [3], but the H7N9 of HPAIVs
broke out and infected human was low pathogenic in
poultry in 2013 [4]; LPAIVs such as H9N2 cause mild or no
symptoms in poultry, wild birds and human, and most AIV
subtypes are LPAIVs [5, 6].
Most H10 subtype AIVs belong to LPAIVs and have been
brought into sharp focus since the winter of 2013. H10N8
was reported to cause human disease for the first time in
December 2013 following the emergence of the H7N9 and
H5N1 subtype AIVs that cause serious disease in humans
and have become a threat to public health [7, 8]. As of 15
February 2014, three cases of human infection with A
(H10N8) virus have been confirmed in Jiangxi Province,
China, of whom two died [9]. H10N8 had been reported
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only two cases that water samples from the Dongting Lake
in 2007 and a duck from Guangdong in 2012 in China
before human cases [10, 11]. Currently, H10 subtype AIVs
are generally well-known as human infection and followed
more focus. Indeed, H10 subtype AIVs have been reported
previously, and some of these viruses can cause disease in
mammals. H10N4 was confirmed to cause interstitial pneu-
monia in minks [12], and H10N5 has been found in pigs
[13]. H10N7 led to increased mortality and decreased egg
production in chickens on a commercial poultry farm in
Australia [14, 15]. Rapid detection is very important for the
prevention and control of AIVs. Methods for the detection
of the H5, H7 and H9 subtypes of AIVs have been devel-
oped and applied to surveillance and clinical care [16]. Cur-
rently, rapid assays for the detection and surveillance of
H10 subtype AIVs are not available, and the development
of an effective and applicable assay is urgently needed.
The loop-mediated isothermal amplification (LAMP)
technique was invented in 2000 [17] and provides a power-
ful gene amplification tool with simple conditions requiring
only a water bath at 58–65 °C and a 30–60 min incubation.
LAMP amplification relies on the Bst DNA polymerase
with highly auto-cycling strand displacement DNA synthe-
sis activity. RT-LAMP assay is being used widely for the
detection of AIVs such as H1, H3 and H9 subtypes and
various viral pathogens [18–23]. In recent years, improve-
ments in the LAMP assay, such as visual detection of amp-
lified product by adding calcein or hydroxynaphthol blue
(HNB) [24], which only require a temperature-controlled
water bath and effectively avoid nucleic acid production
pollution, have made it easier to apply in primary clinical
setting or for field use. In this study, we developed an
effective RT-LAMP assay with calcein and MnCl2 [25], to
visual detect the H10 subtype AIVs, which might be suit-
able in the surveillance of the H10 subtype of AIVs for the




The HA gene sequences of the H10 subtype AIVs
were available downloaded from the NCBI Influenza
Virus Resource Database and were compared and an-
alyzed using the DNAstar software to identify con-
served regions. Several primer sets were designed
within the conserved regions using the LAMP primer
design software (Primer Explorer V4 http://primerex-
plorer.jp/elamp4.0.0/index.html) for used in the H10-
RT-LAMP assays. The specificity of the primer sets
was evaluated using NCBI BLAST to confirm that no
cross-reactivity with sequences from other avian path-
ogens would occur. Finally, an optimal set of primers
was chosen after many rounds of analysis to ensure
the highest specificity and sensitivity of the H10-RT-
LAMP assay. The RT-LAMP primer set consists of two
outer primers (F3 and B3), two inner primers (FIP and BIP,
FIP = F1c + F2, BIP = B1c + B2), and two loop primers (LF
and LB). The high-performance liquid chromatography
(HPLC)-purified primer information is shown in Table 1.
Viral strains and DNA/RNA extraction
The reference and isolate strains or inactive strains (H5,
H7, H14, H15 and H16) of AIV, human influenza virus
(H1N1, H3N2, and Influenza B viruses), other avian patho-
gens and clinical samples used in this study are listed in
Tables 2 and 3. The genomic DNA/RNA was extracted
from 200 μL samples using a DNA/RNA Miniprep kit
(Takara, Dalian, China) according to the protocol suggested
by the manufacturer. The DNA and RNA were eluted with
40 μL of elution buffer and immediately stored at −80 °C
until use.
RT-LAMP reaction
The H10-RT-LAMP assay was performed in a 25 μL reac-
tion containing 2.5 μL 10 ×Thermopol Reaction Buffer
(New England Biolabs, Beijing, China), 8 U Bst DNA poly-
merase (large fragment; New England Biolabs, Beijing,
China), 200 U reverse transcriptase M-MLV (Takara,
Dalian, China), primers (for FIP and BIP, 1.6 μM each, for
F3 and B3, 0.2 μM each, and for LF and LB, 0.8 μM of
each), and 2 μL of the template RNA. Based on previous
studies [18–23], the final concentration ranges of the three
primary reagents, dNTPs (Takara, Dalian, China) (0.2 to
1.6 mM), betaine (Sigma-Aldrich) (0.2 to 1.4 M), and
MgSO4 (Sigma-Aldrich) (2 to 9 mM), were optimized for
amplification efficiency. The amplification reaction was
tested at 58 to 65 °C for 30 to 60 min to find the optimal
temperature and incubation time. Finally, the reaction was
terminated by heating at 80 °C for 5 min. All the experi-
ments were repeated three times.
Real-time monitoring of turbidity at the desired
temperature was achieved by using an LA-320CE turbid-
imeter (Eiken Chemical Co. Ltd. Tochigi, Japan) that
recorded the optical density (OD) at 650 nm every 6 s.
Table 1 Primer information
Name Primer sequences (5′-3′) Genome position
FIP = F1c + F2 CATTGTGTGAGAAGGTGATATTA F1c, 794-772
-ACAATTTTGTTCCGGTTGTTG F2, 681-701






Genome position according to the HA gene of A/duck/Guangdong/E1/
2012(H10N8) (GenBank accession no JQ924786.1)
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Turbidity values greater than 0.1 were considered positive.
In addition to the turbidity meter, reaction results could
be observed visually based on a color changes of green for
positive and orange for negative results by using 25 μM
calcein (Eiken Chemical, Tochigi, Japan) combined with
0.5 mMMnCl2 (Eiken Chemical, Tochigi, Japan).
In vitro transcription
Following the extraction of RNA from the A/duck/HK/
876/80 (H10N3) strain, the HA gene was amplified by
RT-PCR using previously reported primers [26]. The
purified PCR product was cloned into the pGEM T-
easy vector and transformed into Escherichia coli DH5α
cells. The plasmid, named H10-pGEM, was sequenced
and linearized using the restriction endonuclease Spe I.
The plasmid was then used as a template for the RiboMax
T7 (Promega, Madison, WI) in vitro transcription system
according to the manufacturer’s instructions. After
DNase treatment to eliminate residual DNA, the RNA
product was purified using a RNA purification kit
(Tiangen, Beijing), and its concentration was determined
spectrophotometrically using a NanoDrop 2000 (Thermo
Table 2 Sources of pathogens analyzed and H10-RT-LAMP assay results
Number Virus strain Source Titre H10-RT-LAMP GenBank accession or
laboratory references
1 A/duck/Guangxi/030D/2009 (H1N1) GVRI 105.5EID50/mL - KC608160
2 A/duck/Guangxi/N42/2009 (H3N2) GVRI 105.4EID50/mL - JN003630
3 A/duck/Guangxi/GXd-4/2009 (H6N6) GVRI 106.8EID50/mL - JX304746.1
4 A/turkey/Ontario/6118/1967 (H8N4) UCONN 106.3EID50/mL - GU053171.1
5 A/duck/Guangxi/RX/2009 (H9N2) GVRI 106.9EID50/mL - KF768236.1
6 A/duck/Guangxi/LAD9/2009 (H9N8) GVRI 107.1EID50/mL - KF768214.1
7 A/Turkey/MN/3/1979 (H10N7) UCONN 106.7EID50/mL + GU186627.2
8 A/duck/Alberta/60/1976 (H12N5) UCONN 106.3EID50/mL - AB288334
9 A/gull/Maryland/704/1977 (H13N6) UCONN 106.5EID50/mL - D90308.1
10 A/mallard duck/Astrakhan/263/1982 (H14N5) UCONN 106.2EID50/mL - CY014604.1
11 A/wedge-tailed shearwater/Western Australia/2576/1979 (H15N9) UCONN 105.4EID50/mL - CY006010.1
12 A/shorebird/Delaware/168/2006(H16N3) UCONN 106.0EID50/mL - EU030976.1
13 Newcastle disease virus (NDV): Lasota GVRI 108.0EID50/mL - JF950510.1
14 Infectious bronchitis virus (IBV): M41 GVRI 108.3EID50/mL - DQ834384
15 Infectious laryngotracheitis virus (ILTV) GVRI 105.8EID50/mL - NC_006623.1
16 A/Mallard/Alberta/77 (H2N3) UCONN 106.0EID50/mL - Peng Y et al. (2011) [19]
17 A/Turkey/GA/209092/02 (H5N2) UCONN 107.8EID50/mL - Peng Y et al. (2011) [19]
18 A/Turkey/CA/35621/84 (H5N3) UCONN 106.5EID50/mL - Peng Y et al. (2011) [19]
19 A/waterfowl/GA/269452-56/03 (H5N7) UCONN 107.0EID50/mL - Peng Y et al. (2011) [19]
20 A/Turkey/WI/68 (H5N9) UCONN 107.2EID50/mL - Peng Y et al. (2011) [19]
21 A/Chicken/NY/273874/03 (H7N2) UCONN 107.0EID50/mL - Peng Y et al. (2011) [19]
22 A/Duck/HK/876/80 (H10N3) HKU 106.0EID50/mL + Xie Z et al. (2006) [16]
23 A/Chicken/Guangxi/90C/2011 (H1N2) GVRI 106.3EID50/mL - HA and HI test
24 A/Duck/Guangxi/070D/2010 (H4N6) GVRI 106.2EID50/mL - HA and HI test
25 A/chicken PA/3979/97 (H7N2) PU 106.6EID50/mL - HA and HI test
26 A/duck/PA/2099/12 (H11N9) PU 106.0EID50/mL - HA and HI test
27 A/Guangxi/1415/15 (H1N1) GXCDC 105.8EID50/mL - HA and HI test
28 A/Guangxi/1241/14 (H1N1) GXCDC 106.0EID50/mL - HA and HI test
29 A/Guangxi/1420 /15 (H3N2) GXCDC 105.6EID50/mL - HA and HI test
30 A/Guangxi/1632/15 (H3N2) GXCDC 106.2EID50/mL - HA and HI test
31 B/Guangxi/1418/15 GXCDC 105.8EID50/mL - HA and HI test
32 B/Guangxi/1470/15 GXCDC 105.6EID50/mL - HA and HI test
GVRI Guangxi Veterinary Research Institute, Nanning, Guangxi, China; UCONN University of Connecticut, USA; PU University of Pennsylvania, USA; HKU University of
Hong Kong, China; GXCDC Guangxi Provincial Center for Disease Control and Prevention, China
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Scientific, USA). The in vitro transcribed RNA was se-
quenced to further evaluate the direction of insert and the
length. The right RNA transcribed from the HA gene
from the H10 subtype AIVs was 10-fold serially diluted
from 104copies/μL to 1copy/μL as standard quantitatively.
Specificity and sensitivity of the assay
To evaluate the specificity of the primer set used for the
H10-RT-LAMP assay, DNA/RNA extracted from AIV
subtypes H1, H2, H3, H4, H5, H6, H7, H8, H9, H10, H11,
H12, H13, H14, H15, H16, human influenza viruses
(H1N1, H3N2 and influenza B viruses), Newcastle disease
virus (NDV), infectious bronchitis virus (IBV), and infec-
tious laryngotracheitis virus (ILTV) were analyzed using the
H10-RT-LAMP assay.
A 10-fold dilution series vitro-transcribed RNA ranging
from 104 copies/μL to 1copy/μL served as the standard to
test the sensitivity of this assay. All reactions were per-
formed in triplicate.
Clinical sample detection
This study was approved, and the protocol sample
collection was conducted by the Animal Ethics Com-
mittee of the Guangxi Veterinary Research Institute,
which supervises all live bird markets (LBMs) in
Guangxi province. Oral and cloacal swab samples
were gently collected with permission from the
owners of LBMs, and the fowls were not anesthetized
before sampling and were observed for 30 min after
sampling before being returned to their cages. The
clinical samples were prepared in a viral transport
medium, which was made up of 0.05 M phosphate
buffered saline (PBS) containing antibiotics of penicil-
lin (10,000 units/ml), streptomycin (10 mg/ml), genta-
mycin (10 mg/ml), kanamycin (10 mg/ml) and 5 % (v/v)
fetal bovine serum, and were placed in the ice box.
A total of 1296 clinical swab samples (Table 3)
including healthy chickens, duck, geese, francolins and
pigeons were collected from five LBMs named Xiuxiang
(No.1-246), Beihu (No.247-525), Sulu (No.526-813),
Danchun ((No.814-1102) and Jiangqiao (No.1103-1296)
in Nanning in Guangxi province and assayed by
RT-LAMP and virus isolation. Virus isolations were
prepared by inoculating specific-pathogen-free (SPF)
embryonated chicken eggs and were tested using a
hemagglutination assay (HA) and a hemagglutination in-
hibition (HI) assay described previously [27].
Results
Optimization of H10-RT-LAMP
Following standardization and optimization, the optimal of
final concentrations were 1.4 mM each dNTP, 0.8 M beta-
ine, 6 mM MgSO4. The H10-RT-LAMP reactions were
incubated at 63 °C for 40 min and then heat-inactivated at
80 °C for 5 min to terminate the reaction.
Specificity and sensitivity of the H10-RT-LAMP assay
As expected, the turbidity value of the H10 subtype AIVs
gradually increased at 20 min. We observed that the in-
creased turbidity curve appeared only when H10 subtype
AIVs was used as the template that indicated a positive re-
sult, while straight lines were observed for the other avian
pathogens (H1-H9 AIV, H11-H16 AIV, human influenza
viruses, NDV, IBV and ILTV) indicating a lack of amplifi-
cation (Fig. 1a). A green color was observed for the H10
subtype AIVs, and the other reactions remained the same
orange color as before the incubation (Fig. 1b). The results
of the detection assay for each strain are shown in Table 2.
All the results suggest that this newly developed RT-LAMP
assay only amplifies H10 subtype AIVs and shows no cross-
reactivity with other avian pathogens and human influenza
viruses (H1N1, H3N2 and influenza B virus), thus val-
idating the high specificity of this H10-RT-LAMP
assay. The sensitivity of the test was established by
dilution series vitro-transcribed RNA standard sam-
ples. The LOD for the RT-LAMP was 10 copies/μL
(Fig. 2a and b). Direct visualization of the Calcein dye-
aided color change not only determined amplification but
also did not require expensive instruments, needing only a
temperature-controlled water bath, and the calcein dye re-
sults were consistent with the turbidity data.
Clinical sample detection
To evaluate the sensitivity of the H10-RT-LAMP assay in
clinical practice, a total of 1296 oral and cloacal swab sam-
ples were collected and subjected to methods of detection
in parallel: H10-RT-LAMP, and viral isolation. Of the 1296
oral and cloacal swab samples tested, 8 were confirmed to
be positive for H10 subtype AIVs for both RT-LAMP and
viral isolation (Table 3).
Discussion
According to the World Organisation for Animal Health
(OIE), HPAIVs includes two characteristic i) high
pathogenic in vivo and ii) presence of multiple basic
Table 3 Results of two assays for the detection of H10 subtype





Number of positive samples
LAMP Viral isolation
Chicken 198 0 0
Duck 611 4 4
Geese 234 2 2
Francolin 134 1 1
Pigeon 119 1 1
Total 1296 8 8
Luo et al. Virology Journal  (2015) 12:145 Page 4 of 7
amino acids at the HA cleavage site. Significantly, there
were two H10 subtype AIVs [A/turkey/England/384/
79(H10N4) and A/mandarin duck/Singapore/805/F-72/7/
93(H10N5)] that lacked multi-basic amino acids at the
HA cleavage site, a typical marker for HPAIVs, but are
highly virulent in chickens according to the test in vivo,
and been reported as HPAIVs by both the OIE and the EU
definitions [28, 27]. Some findings have suggested that the
HA molecule of H10 subtypes may have an affinity for
human cell receptors and may also help the virus to adapt
to multiply in humans [29]. Therefore, similar to H7N9,
the first sign of a poultry infection could be the emergence
of clinical cases of H10N8 in humans, which would then
lead to the identification of silent outbreaks in poultry [8].
Therefore, the development of a simple, rapid, visual and
effective assay for H10 subtype AIVs diagnosis would sig-
nificantly aid efforts to control this disease. We need to
enhance surveys and collect samples monthly, quarterly
and annually to monitor the H10 subtype AIVs.
Virus isolation is a gold standard and fundamental diag-
nostic method for the detection of AIVs, the results are
accurate and reliable, but the procedure is time consuming
labor intensive to inoculate embryonated chicken egg for
2–5 days and harvest allantoic fluid for HI identification re-
quiring the positive serum of multiple subtypes AIVs. Other
molecular biological diagnostic techniques, such as conven-
tional reverse transcription polymerase chain reaction (RT-
PCR) and quantitative real-time RT-PCR (qRT-PCR) have
been not reported for H10 subtype AIVs.
We see several obvious advantages of the RT-LAMP
assay: 1) The specificity and sensitivity are greatly enhanced
by six primers recognizing eight independent target se-
quence regions, whereas conventional RT-PCR primers
only recognize two independent regions. 2) The RT-LAMP
assay only requires small amounts of cDNA to accomplish
efficient amplification. Furthermore, reverse transcription
can proceed at the same temperature, 58–67 °C, as the
LAMP reaction. Therefore, the two reactions can run at
the same time, making LAMP a one-step assay for RNA-
based pathogens that require reverse transcription for
Fig. 1 Specificity results of the H10-RT-LAMP assay. a The turbidity curve of the RT-LAMP products. b Visualization of the RT-LAMP products. 1,
H10N3; 2, H1N1; 3, H3N2; 4, H5N3; 5, H6N8; 6, H7N2; 7, H9N2; 8, H11N9; 9, NDV; 10, IBV; 11, ILTV; 12, blank control
Fig. 2 Sensitivity results of the H10-RT-LAMP assay. a The turbidity
curves of the RT-LAMP products from a 10-fold dilution series of
RNA. b Visualization of the RT-LAMP products from a 10-fold dilution
series of RNA. 1, 104 copies/μL; 2, 103 copies/μL; 3, 102 copies/μL; 4,
10 copies/μL; 5, 1 copy/μL; 6, blank control
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molecular detection. 3) RT-LAMP is simple and easy to
perform and only requires a temperature-controlled water
bath, making it suitable for primary clinical settings or field
use. Therefore, we believe that this simple, fast, and
effective assay might be applied to the field detection
of H10 subtype AIVs infections. The RT-LAMP assay
has many advantages as mentioned above, there is still a
problem to note. The RT-LAMP assay has great amplifica-
tion efficiency so the reaction product can form aerosol to
contaminate the surroundings when opening the tube. To
avoid the contamination in this study, the fluorescence re-
agent (Calcein and MnCl2) were added to RT-LAMP reac-
tion mixture before amplification in order to inspect the
result of RT-LAMP assay directly with the naked eye.
In this study, we used calcein’s color change to visually
determine results; we also monitored turbidity using the
Loopamp Realtime Turbidimeter. To our knowledge,
this is the first study to explore the use of H10 AIVs
LAMP technology in a diagnostic test for H10 AIVs.
This assay and its analysis are simple, specific, sensitive
and rapid, do not require special equipment, and can be
applied to detect H10 AIVs in clinical samples.
Conclusions
In summary, this newly developed H10-RT-LAMP assay is
a specific, sensitive, rapid, and cost-effective assay for the
rapid detection and epidemiological surveillance of the H10
subtype AIVs. It can be applied to the rapid visual diagnosis
of clinical samples and can also provide an effective tool to
prevent and control H10 subtype AIVs disease.
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